A population analysis of VEGF transgene expression and secretion
暂无分享,去创建一个
[1] F. Torti,et al. Recombinant ferritin: modulation of subunit stoichiometry in bacterial expression systems. , 1997, Protein engineering.
[2] Diane J Burgess,et al. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[3] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[4] J. Isner,et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[5] H. Mizuguchi,et al. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] C. Ricordi,et al. Transplantation: current developments and future directions; the future of clinical islet transplantation as a cure for diabetes. , 2008, Frontiers in bioscience : a journal and virtual library.
[7] D. Stewart,et al. Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene Transfer Materials and Methods Cell Isolation and Culture , 2022 .
[8] H. Blau,et al. Critical role of microenvironmental factors in angiogenesis , 2005, Current atherosclerosis reports.
[9] Todd D. Giorgio,et al. Transfection by Cationic Liposomes Using Simultaneous Single Cell Measurements of Plasmid Delivery and Transgene Expression* , 1997, The Journal of Biological Chemistry.
[10] Y. Yoon,et al. Therapeutic myocardial angiogenesis with vascular endothelial growth factors , 2004, Molecular and Cellular Biochemistry.
[11] G. Rubanyi,et al. The future of human gene therapy. , 2001, Molecular aspects of medicine.
[12] Doris A Taylor,et al. Cell–based cardiovascular repair , 2005, Basic Research in Cardiology.
[13] F. Wurm,et al. Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. , 2001, Gene.
[14] B. Oh,et al. Two‐promoter vector is highly efficient for overproduction of protein complexes , 2004, Protein science : a publication of the Protein Society.
[15] D. Dean,et al. Nonviral Gene Transfer Strategies for the Vasculature , 2002, Microcirculation.
[16] M. D. Brown,et al. Gene delivery with synthetic (non viral) carriers. , 2001, International journal of pharmaceutics.
[17] D. Stewart,et al. Cell therapy for pulmonary hypertension: what is the true potential of endothelial progenitor cells? , 2004, Circulation.
[18] M. Chopp,et al. Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats , 2001, Stroke.
[19] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[20] Shay Soker,et al. Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*) , 1996, The Journal of Biological Chemistry.
[21] J. Isner,et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. , 1995, Circulation.
[22] D. Nolte,et al. Restoration of blood flow and evaluation of corresponding angiogenic events by scanning electron microscopy after a single dose of VEGF in a model of peripheral vascular disease , 2004, Angiogenesis.
[23] Amit N. Patel,et al. Cell based approaches for myocardial regeneration and artificial myocardium. , 2007, Current stem cell research & therapy.
[24] J. Isner,et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. , 1996, Circulation.
[25] Yasuo Shinohara,et al. Quantitative Analysis of Correlation Between Number of Nuclear Plasmids and Gene Expression Activity After Transfection with Cationic Liposomes , 2002, Pharmaceutical Research.
[26] H. Blau,et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.
[27] J. Folkman,et al. Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border , 1998, Cell.
[28] D. Stewart,et al. Cell-Based Gene Transfer of Vascular Endothelial Growth Factor Attenuates Monocrotaline-Induced Pulmonary Hypertension , 2001, Circulation.
[29] D H Kohn,et al. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. , 2000, Biomaterials.
[30] A. Secchi,et al. Pancreatic islet cell transplant for treatment of diabetes. , 2007, Endocrinology and metabolism clinics of North America.
[31] Holger Gerhardt,et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis , 2007, Nature.
[32] Takayuki Asahara,et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.
[33] J. Isner,et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. , 1995, Journal of vascular surgery.
[34] Holger Gerhardt,et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. , 2002, Genes & development.
[35] N. Ferrara. Molecular and biological properties of vascular endothelial growth factor , 1999, Journal of Molecular Medicine.
[36] Wong,et al. Biological barriers to cellular delivery of lipid-based DNA carriers. , 1999, Advanced drug delivery reviews.
[37] Bart Landuyt,et al. Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.